Related Experiment Video
Updated: Jul 5, 2026

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
Published on: January 12, 2024
[Acute generalized exanthematous pustulosis associated with diltiazem]
Vasco Serrão1, Luísa Caldas Lopes, J M Campos Lopes
1Serviço de Dermatologia, Hospital dos Capuchos, Lisboa.
Acute generalized exanthematous pustulosis (AGEP) is a rare drug-induced skin reaction. This case highlights diltiazem as a potential cause, confirmed by patch testing, emphasizing AGEP
Area of Science:
- Dermatology
- Pharmacology
Background:
- Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous adverse drug reaction.
- It typically presents with fever and widespread pustules on erythematous skin.
- Drugs are implicated in nearly 90% of AGEP cases, with antibiotics being common culprits.
Observation:
- A 36-year-old female developed AGEP after initiating diltiazem for hypertension.
- The patient presented with fever, edema, and erythematous lesions with sterile pustules.
- Symptoms resolved with oral corticosteroid treatment.
Findings:
- Patch testing confirmed diltiazem as the causative agent for AGEP in this patient.
- This case expands the known spectrum of drugs triggering AGEP.
- Positive patch test reactions are frequently observed in drug-induced AGEP.
Implications:
- AGEP should be considered in the differential diagnosis of acute pustular eruptions, especially when accompanied by fever.
- Diltiazem is identified as a potential, albeit uncommon, trigger for AGEP.
- Diagnostic patch testing can be valuable in identifying the specific drug responsible for AGEP.
Related Concept Videos
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Diphtheria
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Drug Toxicity: Allergic Reactions
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease I: Introduction